Sarclisa Escena FDA Approval: Sanofi Transforms Multiple Myeloma...

ha aggiunto una foto Health

2026-09-09 11:56:16 - Translate -

Sarclisa Escena FDA Approval: Sanofi Transforms Multiple Myeloma Treatment Delivery

Sanofi has reached an important milestone in multiple myeloma management with the U.S. approval of Sarclisa Escena, a subcutaneous formulation of isatuximab-irfc administered using the CirCLIQ on-body injector. The U.S. Food and Drug Administration granted approval on July 9, 2026, marking the first anticancer therapy cleared for administration through an on-body injector. This development...

0 Commenti 0 condivisioni 144 Views 0 Anteprima